Favorable cardiac risk among elderly breast carcinoma survivors.
Conti
Elena
E
Marchese
Nicola
N
Andreotti
Felicita
F
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001682:Biological Availability; D001943:Breast Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology / Q000401:mortality; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000276:immunology*; D009203:Myocardial Infarction / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D011379:Prognosis; D015203:Reproducibility of Results; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D007334:Insulin-Like Growth Factor I